Clinical trial
Bronchiectasis and Long Term Azithromycin Treatment
NCT00415350 · W.G.Boersma, Other · Completed
Key facts
| NCT number | NCT00415350 |
|---|---|
| Title | Bronchiectasis and Long Term Azithromycin Treatment |
| Official title | Bronchiectasis and Long Term Azithromycin Treatment: A Randomised Placebo-controlled Trial Studying Disease Modifying Effects of Immunomodulating Treatment |
| Acronym | BAT |
| Lead sponsor | W.G.Boersma, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bronchiectasis, Inflammation |
| Intervention type | Drug, Other |
| Interventions | Azithromycin, Placebo |
| Enrollment | 72 |
| Start date | Apr 1, 2008 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2010 |
| First posted | Dec 22, 2006 |
| Last update posted | May 28, 2020 |
| Countries | Netherlands |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: